TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20102858

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (family-centered program with 12 sessions of behavioral curriculum, dietary advice from a registered dietitian weekly for the first 3 months and monthly thereafter, and monthly consultations with a primary care physician)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (monthly consultations with a primary care physician who received brief training on obesity)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study: 16787761

Group type: EXPERIMENTAL
Intervention: 1% diclofenac gel
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Diclofenac tablets
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Paracetamol tablets
Number of subjects: 42
Study: 16095062

Group type: EXPERIMENTAL
Intervention: 100 mg oral tramadol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12386639

Group type: EXPERIMENTAL
Intervention: Methylprednisolone alone (0.3 mg/kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Diltiazem alone (180 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Methylprednisolone-diltiazem combination
Number of subjects: 5

Group type: COMPARATOR
Intervention: Methylprednisolone alone
Number of subjects: 5
Study: 10646171

Group type: EXPERIMENTAL
Intervention: Clustered sleep fragmentation (every 30 s for 30 min every 90 min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Regular sleep fragmentation (every 90 s)
Number of subjects: 16
Study: 7845114

Group type: EXPERIMENTAL
Intervention: Pulsed intrope therapy (PIT) with dobutamine, infused to raise heart rate to 70-80% maximum for 30 min per day, 4 days per week for 3 weeks
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pulsed intrope therapy (PIT) with dobutamine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 2347075

Group type: EXPERIMENTAL
Intervention: High water content non‐HEMA (ofilcon A) lens (Durasoft 4; Wesley‐Jessen)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mid‐water content modified HEMA material
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low water content HEMA and non‐HEMA materials
Number of subjects: 20
Study: 44632

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (2 mg on the night before operation followed by 2 mg on the morning of operation)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Flunitrazepam
Number of subjects: 81

Group type: COMPARATOR
Intervention: Flunitrazepam and Placebo
Number of subjects: 81
Study: 30874457

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 28655302

Group type: EXPERIMENTAL
Intervention: Reusable sanitary pads
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Puberty education
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Education with reusable sanitary pads
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study: 25885963

Group type: EXPERIMENTAL
Intervention: Tight glucose control
Number of subjects: 1114

Group type: COMPARATOR
Intervention: SHINE design
Number of subjects: 1114

Group type: COMPARATOR
Intervention: Goldilocks design
Number of subjects: 1114
Study: 23506216

Group type: EXPERIMENTAL
Intervention: NeuroAiD (four capsules three times daily for three months)
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Placebo (four capsules three times daily for three months)
Number of subjects: 1100
Study: 21298400

Group type: EXPERIMENTAL
Intervention: Mujeres en Accion intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19616774

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard wound dressing
Number of subjects: 24
Study: 17846459

Group type: EXPERIMENTAL
Intervention: Feedback on daily step counts (monitoring and recording step counts during week 1)
Number of subjects: 105

Group type: COMPARATOR
Intervention: No feedback condition (sealed pedometer during week 2)
Number of subjects: 105
Study: 15025611

Group type: EXPERIMENTAL
Intervention: 27-G (0.41 mm) Quincke spinal needle
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: 27-G (0.41 mm) Whitacre spinal needle
Number of subjects: 676

Group type: COMPARATOR
Intervention: Both Quincke and Whitacre spinal needles
Number of subjects: 676
Study: 11570932

Group type: EXPERIMENTAL
Intervention: music‐assisted reframing intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: typical reframing intervention
Number of subjects: 40
Study: 9748859

Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary angioplasty (PTCA)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Intravenous thrombolysis
Number of subjects: 82
Study: 7531457

Group type: EXPERIMENTAL
Intervention: P. carinii cluster ratios
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Erythrosin B (vital stain for P. carinii viability)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 35-45 kD antigen
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 95 kD antigen
Number of subjects: 96

Group type: COMPARATOR
Intervention: 52 and 66 kD antigens
Number of subjects: 96
Study: 3263599

Group type: EXPERIMENTAL
Intervention: Healon
Number of subjects: 60

Group type: COMPARATOR
Intervention: Viscoat (irrigated/aspirated)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Viscoat (left in the eye)
Number of subjects: 60
Study: 31491040

Group type: EXPERIMENTAL
Intervention: Levothyroxine (L-T4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28733983

Group type: EXPERIMENTAL
Intervention: Trastuzumab emtansine (T-DM1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment of physician's choice (TPC)
Number of subjects: 0
Study: 26407753

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 5395

Group type: COMPARATOR
Intervention: Enoxaparin followed by warfarin
Number of subjects: 5395
Study: 23085329

Group type: EXPERIMENTAL
Intervention: Weight management text-messages (2-5 messages per day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual-care comparison group
Number of subjects: 52
Study: 21763936

Group type: EXPERIMENTAL
Intervention: Rilpivirine (25 mg once daily)
Number of subjects: 690

Group type: COMPARATOR
Intervention: Efavirenz (600 mg once daily)
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Rilpivirine
Number of subjects: 690

Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 690
Study: 19427433

Group type: EXPERIMENTAL
Intervention: Low chronotropic index
Number of subjects: 920
Study: 16766777

Group type: EXPERIMENTAL
Intervention: ExCHO - Subjects exercised on a cycle ergometer at 70% VO2peak with a net energy cost of 400 kcal, followed by consumption of a high carbohydrate (CHO) energy bar
Number of subjects: 8

Group type: COMPARATOR
Intervention: NoExCHO - Subjects sat quietly rather than exercised, followed by consumption of a high carbohydrate (CHO) energy bar
Number of subjects: 8

Group type: COMPARATOR
Intervention: NoExGlc - Subjects consumed a 50 g glucose (glc) drink as the reference CHO for GI and insulinemic index (II) determination
Number of subjects: 8
Study: 15127867

Group type: EXPERIMENTAL
Intervention: Giomer composite
Number of subjects: 40

Group type: COMPARATOR
Intervention: Microfilled composite
Number of subjects: 40
Study: 11331845

Group type: EXPERIMENTAL
Intervention: Subfascial endoscopic division of incompetent perforating veins (SEPS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Open subfascial division of incompetent perforating veins (Linton procedure)
Number of subjects: 39
Study: 9154401

Group type: EXPERIMENTAL
Intervention: terbinafine (250 mg daily)
Number of subjects: 118

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 118
Study: 8097683

Group type: EXPERIMENTAL
Intervention: Metoprolol (10‐15 mg plus 150 micrograms min‐1 kg‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 12
Study: 2892252

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nizatidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30498827

Group type: EXPERIMENTAL
Intervention: High-protein dairy-based products and energy-enriched berry purées for three months, providing nearly 300 kcal and 14 g protein per day.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (not specified).
Number of subjects: 85
Study: 26831176

Group type: EXPERIMENTAL
Intervention: Deworming regimen (DR)
Number of subjects: 615
Study: 25113056

Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
Number of subjects: 15
Study: 23221739

Group type: EXPERIMENTAL
Intervention: Calcifediol supplementation
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Calcifediol supplementation with concomitant active vitamin D
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Calcifediol supplementation in patients with suppressed baseline PTH
Number of subjects: 217
Study: 20956208

Group type: EXPERIMENTAL
Intervention: Acetaminophen (1 g TID for 2 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 18761644

Group type: EXPERIMENTAL
Intervention: Insulin detemir (0.4 U/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Insulin detemir (0.4 U/kg) in children (8-12 years)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Insulin detemir (0.4 U/kg) in adolescents (13-17 years)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Insulin glargine (0.4 U/kg)
Number of subjects: 32
Study: 15850630

Group type: EXPERIMENTAL
Intervention: Supervised intake of artemether-lumefantrine (all doses observed with fatty-food intake; n=313)
Number of subjects: 957

Group type: COMPARATOR
Intervention: Unsupervised intake of artemether-lumefantrine (first dose supervised followed by outpatient treatment with nutritional advice; n=644)
Number of subjects: 957
Study: 12452220

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine + intravenous ketorolac
Number of subjects: 107

Group type: COMPARATOR
Intervention: Intravenous ketorolac alone
Number of subjects: 107
Study: 10777467

Group type: EXPERIMENTAL
Intervention: Platinum-based combination chemotherapy administered sequentially or concurrently with thoracic radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thoracic radiation therapy combined with novel drugs or new drug combinations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatin in combination with thoracic radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined modality therapy with thoracic radiation therapy
Number of subjects: 0
Study: 9105526

Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8245373

Group type: EXPERIMENTAL
Intervention: Dietary intervention group (n = 328)
Number of subjects: 652

Group type: COMPARATOR
Intervention: Control group (n = 324)
Number of subjects: 652
Study: 3698062

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetaminophen with codeine
Number of subjects: 40
Study: 30081868

Group type: EXPERIMENTAL
Intervention: mHealth YWC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Face-to-face YWC
Number of subjects: 0

Group type: COMPARATOR
Intervention: HIV counseling and testing (HCT)
Number of subjects: 0
Study: 26941282

Group type: EXPERIMENTAL
Intervention: Brincidofovir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25127924

Group type: EXPERIMENTAL
Intervention: Probiotic (Bacillus coagulans GBI-30, 6086 capsule)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 17
Study: 22394457

Group type: EXPERIMENTAL
Intervention: Continued cannabis use
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control (no cannabis use)
Number of subjects: 124
Study: 20542068

Group type: EXPERIMENTAL
Intervention: LKFibre-containing foods
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control foods
Number of subjects: 38
Study: 18684197

Group type: EXPERIMENTAL
Intervention: On PPI
Number of subjects: 30

Group type: COMPARATOR
Intervention: Off PPI
Number of subjects: 30
Study: 16421034

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment (lanzoprazole, clarithromycin, and amoxicillin) for 8 days
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii plus inulin (SbI) daily for 8 weeks
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus LB (LB) daily for 8 weeks
Number of subjects: 182

Group type: COMPARATOR
Intervention: Untreated children (spontaneous clearance)
Number of subjects: 182
Study: 14519710

Group type: EXPERIMENTAL
Intervention: CT-3 (four 10-mg capsules per day for the first 4 days, then 8 capsules per day in 2 daily doses for the following 3 days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (identical capsules)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: CT-3
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: CT-3 and Placebo
Number of subjects: 21
Study: 10792337

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine oestrogen (CEE)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 0.3 mg conjugated equine oestrogen (CEE)
Number of subjects: 124

Group type: COMPARATOR
Intervention: 0.625 mg and 0.3 mg conjugated equine oestrogen (CEE)
Number of subjects: 124
Study: 8785958

Group type: EXPERIMENTAL
Intervention: Diphtheria-tetanus vaccine adsorbed to aluminium hydroxide
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Diphtheria-tetanus vaccine adsorbed to calcium phosphate
Number of subjects: 313

Group type: COMPARATOR
Intervention: Reduced potency assay
Number of subjects: 313
Study: 30595443

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual-care waiting-list control group
Number of subjects: 66
Study: 29753099

Group type: EXPERIMENTAL
Intervention: Dyspnea Exertion Scale (DES)
Number of subjects: 188

Group type: COMPARATOR
Intervention: modified Medical Research Council (mMRC)
Number of subjects: 188
Study: 26967157

Group type: EXPERIMENTAL
Intervention: Insecticide treated curtains (ITCs) distributed to 593 households as part of a cluster-randomized trial.
Number of subjects: 1333

Group type: EXPERIMENTAL
Intervention: Participants who were housewives, knew three or more correct symptoms of dengue, knew at least one correct treatment for dengue, knew someone who had dengue, had children sleeping under a mosquito net, or perceived a change in mosquito amounts.
Number of subjects: 1333

Group type: EXPERIMENTAL
Intervention: Participants who perceived a change in the amount of mosquitoes in the home.
Number of subjects: 1333
Study: 24147647

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Number of subjects: 20

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 20
Study: 22352435

Group type: EXPERIMENTAL
Intervention: Lacto-Wolfberry (13.7 grams/day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Lacto-Wolfberry
Number of subjects: 150
Study: 18988089

Group type: EXPERIMENTAL
Intervention: Topical capsaicin cream 0.025%
Number of subjects: 64

Group type: COMPARATOR
Intervention: Betamethasone cream 0.1%
Number of subjects: 64
Study: 16859791

Group type: EXPERIMENTAL
Intervention: Usual dopaminergic treatment in PD patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Withdrawal of dopaminergic medication in PD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy participants with hyperechogenicity of the substantia nigra
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute phenylalanine and tyrosine depletion (APTD) in healthy adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control participants (healthy participants with low echogenicity)
Number of subjects: 0
Study: 12599085

Group type: EXPERIMENTAL
Intervention: 2.5 microg MEDI‐491
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 25 microg MEDI‐491
Number of subjects: 24
Study: 10910853

Group type: EXPERIMENTAL
Intervention: Lidocaine with 100 microg fentanyl IV (Group 2)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Lidocaine with normal saline IV (Group 1)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Lidocaine with 100 microg fentanyl IV (Group 3)
Number of subjects: 66
Study: 9361930

Group type: COMPARATOR
Intervention: CsA monitoring with T0 (trough levels)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CsA monitoring with T6 (levels obtained 6 h after the morning dose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CsA monitoring with T0
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CsA monitoring with T6
Number of subjects: 20
Study: 1388616

Group type: EXPERIMENTAL
Intervention: Guide-wire technique
Number of subjects: 159

Group type: COMPARATOR
Intervention: De novo puncture
Number of subjects: 159
Study: 3887850

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg intravenously
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 10
Study: 30089442

Group type: EXPERIMENTAL
Intervention: Participants who mentioned cardiovascular conditions
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Participants who mentioned metabolic conditions
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Participants who named < 3 diseases
Number of subjects: 361
Study: 26897613

Group type: EXPERIMENTAL
Intervention: Unmet psycho-emotional needs
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Unmet coping needs
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Unmet care/support needs
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Unmet information needs related to cancer/treatment
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Unmet information needs related to the health care system
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Unmet information needs related to surveillance
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Help dealing with 'worry'
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Help dealing with anxiety
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Help needing to move on with life
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Help dealing with uncertainty about the future
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Radiation exposure
Number of subjects: 1189

Group type: EXPERIMENTAL
Intervention: Perceived health status
Number of subjects: 1189
Study: 24886552

Group type: EXPERIMENTAL
Intervention: High polyphenol intake (highest quintile)
Number of subjects: 7447

Group type: EXPERIMENTAL
Intervention: Stilbenes
Number of subjects: 7447

Group type: EXPERIMENTAL
Intervention: Lignans
Number of subjects: 7447

Group type: COMPARATOR
Intervention: Flavonoids
Number of subjects: 7447

Group type: COMPARATOR
Intervention: Phenolic acids
Number of subjects: 7447
Study: 23177487

Group type: EXPERIMENTAL
Intervention: Original clopidogrel bisulphate (600 mg loading dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clopidogrel hydrochloride (600 mg loading dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clopidogrel besylate (600 mg loading dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prasugrel (given for 10 days after clopidogrel treatments)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clopidogrel bisulphate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clopidogrel besylate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clopidogrel hydrochloride
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 60
Study: 19523613

Group type: EXPERIMENTAL
Intervention: 50 mg of IM P-in-oil daily for 11 days (group 2)
Number of subjects: 101

Group type: COMPARATOR
Intervention: 50 mg of IM P-in-oil daily for 6 weeks (group 1)
Number of subjects: 101
Study: 18325421

Group type: EXPERIMENTAL
Intervention: Mobile speed cameras introduced at 29 camera sites
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Mobile speed cameras at camera sites
Number of subjects: 29

Group type: COMPARATOR
Intervention: Comparison of crash data before and after camera introduction
Number of subjects: 29
Study: 16855070

Group type: EXPERIMENTAL
Intervention: Febuxostat 80 mg once daily, Indomethacin 50 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Febuxostat 80 mg, Naproxen 500 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 0
Study: 12805333

Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) with autologous stem-cell transplantation (ASCT)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 163
Study: 10817852

Group type: EXPERIMENTAL
Intervention: Behcet's disease patients
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Behcet's disease patients with diastolic dysfunction
Number of subjects: 71
Study: 8640052

Group type: EXPERIMENTAL
Intervention: Information programme on measures to prevent passive smoking, including prolonged communication at one well-child visit and three brochures.
Number of subjects: 443

Group type: COMPARATOR
Intervention: Control group received no information on smoking.
Number of subjects: 443
Study: 1842119

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with eicosapentaenoic acid
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6359877

Group type: EXPERIMENTAL
Intervention: Warfarin and dipyridamole treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18

Group type: COMPARATOR
Intervention: Paired crossover analysis
Number of subjects: 18